[144] QuantumScape Corporation SEC Filing

Rhea-AI Filing Summary

QuantumScape Corporation (QS) Form 144 notice shows a proposed sale of 100,178 Class A common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $904,607.34. The shares were acquired on 08/15/2025 upon RSU vesting and paid as compensation. The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information. The filing documents the broker, estimated sale date of 08/18/2025, and total shares outstanding of 522,939,205, indicating the sale is a small fraction of outstanding stock.

Positive

• Transparent compliance with Rule 144 showing broker, acquisition date, and sale details
• Sale arises from RSU vesting, indicating routine compensation monetization rather than an ad hoc disposition

Negative

• Insider sale of Class A shares could be viewed negatively by some investors despite being small

Insights

Securities Analyst

TL;DR Insiders plan a small, routine sale of vested RSUs; not material to company valuation.

The filing documents a typical Rule 144 notice for sale of vested restricted stock units through a broker. The position—100,178 shares worth about $0.9 million against 522.9 million shares outstanding—is immaterial in size and appears to be routine monetization of compensation. There are no reported sales in the prior three months and the filer affirms no undisclosed material adverse information, which supports a neutral market implication.

Corporate Governance Expert

TL;DR Proper disclosure of RSU-derived sale; governance-compliant but note insider selling.

The notice meets Rule 144 disclosure norms: it identifies the broker, acquisition date, nature of acquisition (RSU vesting), and payment type (compensation). From a governance perspective, transparent filing and representation about material information are positive controls. The sale size relative to outstanding shares is minimal, so it does not signal a governance crisis or major insider liquidity event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza,38th floor New York NY 10004	100178	904607.34	522939205	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/15/2025	RSU vesting	Issuer			154121	08/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is reported in the QS Form 144 filing?

The filing reports a proposed sale of 100,178 Class A shares via Morgan Stanley Smith Barney with an aggregate value of $904,607.34 and an approximate sale date of 08/18/2025.

Why were the QS shares acquired originally?

The shares were acquired on 08/15/2025 as RSU vesting and paid as compensation.

How large is the proposed sale relative to total QS shares outstanding?

The sale of 100,178 shares compares to 522,939,205 shares outstanding, representing a very small fraction of total shares.

Did the filer report other sales of QS securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the filing disclose any undisclosed material information about QuantumScape (QS)?

The filer affirms by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.